Incannex Healthcare Inc. (NASDAQ: IXHL) Stock Information | RedChip

Incannex Healthcare Inc. (NASDAQ: IXHL)


$2.0250
+0.0550 ( +3.32% ) 6.2K

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Market Data


Open


$2.0250

Previous close


$1.9700

Volume


6.2K

Market cap


$35.64M

Day range


$1.9960 - $2.0650

52 week range


$0.9501 - $12.6800

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 68 Nov 14, 2024
def Proxies and info statements 3 Nov 12, 2024
ars Annual reports 1 Nov 12, 2024
pre Proxies and info statements 3 Oct 31, 2024
3 Insider transactions 1 Oct 24, 2024
8-k 8K-related 14 Oct 24, 2024
8-k 8K-related 15 Oct 24, 2024
4 Insider transactions 1 Oct 24, 2024
8-k 8K-related 15 Oct 21, 2024
8-k 8K-related 16 Oct 15, 2024

Latest News